Skip to main content
Chelsea Pinnix, MD, Radiation Oncology, Houston, TX

Chelsea C Pinnix MD PhD


Associate Professor, Residency Program Director

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Dr. Pinnix is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2008 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityInternship, Internal Medicine, 2007 - 2008
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2007

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • GA State Medical License
    GA State Medical License 2022 - 2026
  • TX State Medical License
    TX State Medical License 2010 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • AZ State Medical License
    AZ State Medical License 2022 - 2025
  • LA State Medical License
    LA State Medical License 2022 - 2025
  • MS State Medical License
    MS State Medical License 2022 - 2025
  • Radiation Oncology
    American Board of Radiology Radiation Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Assessment of Radiation Doses Delivered to Organs at Risk Among Patients with Early-Stage Favorable Hodgkin Lymphoma Treated with Contemporary Radiation Therapy  
    Chelsea C Pinnix, Jillian R Gunther, Sarah A Milgrom, Jason Westin, Simrit Parmar, Loretta Nastoupil, Sattva Neelapu, Bouthaina S Dabaja, JAMA Network Open

Abstracts/Posters

  • Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma
    Chelsea Camille Pinnix, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Response-Adapted Radiation Therapy for Orbital Indolent B-cell Lymphoma
    Response-Adapted Radiation Therapy for Orbital Indolent B-cell LymphomaJuly 23rd, 2024
  • ASTRO Celebrates Contributions to Radiation Oncology With 2022 Gold Medals and Other Awards
    ASTRO Celebrates Contributions to Radiation Oncology With 2022 Gold Medals and Other AwardsOctober 26th, 2022
  • Dr. Howard Sandler Voted President-Elect of the American Society for Radiation Oncology (ASTRO)
    Dr. Howard Sandler Voted President-Elect of the American Society for Radiation Oncology (ASTRO)July 13th, 2022
  • Join now to see all

Grant Support

  • UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1UNIVERSITY OF TX MD ANDERSON CAN CTR2019–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: